iProtin is our state-of-the-art immunoassay diagnostic device engineered to deliver rapid and reliable results. Capable of screening Lipoprotein(a) [Lp(a)] in just 40 seconds, iProtin offers an efficient and effective solution for early diagnosis and improved patient care.
Our Lp(a) biosensor and iProtin reader are currently under 510(k) and CLIA waiver application. We invite you to visit our booth to explore how iProtin can play a pivotal role in supporting cardiovascular risk reduction and enhancing clinical outcomes.